HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Shintaro Nemoto Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Nemoto, S. Search for Related Content PubMed Articles by Nemoto, S. Related Collections Related Article

---

Correspondence

Reply

Department of Thoracic and Cardiovascular Surgery, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki, Osaka 569-8686, Japan

(Email: snemoto@poh.osaka-med.ac.jp).

The first 20% of the full text of this article appears below.

To the Editor:

We appreciate the thoughtful comments of Drs Soueide and Rassi [1] regarding our article [2]. As pointed out [1], it is well recognized that cyclic guanosine monophosphate (cGMP) plays a clinically important role in maintaining pulmonary vascular tone (ie, pulmonary vasodilation, even immediately after cardiac surgery). Along with cGMP production therapy with inhaled nitric oxide for pulmonary hypertension [3], sildenafil has recently been recognized as an effective treatment option for various types of pulmonary hypertension and impaired pulmonary circulation [4, 5] by inhibiting degradation of cGMP. In fact, both inhaled nitrous oxide . . . [Full Text of this Article]

Related Article

Oral Sildenafil After Bidirectional Cavopulmonary Shunt

Tony Soueide and Issam Rassi
Ann. Thorac. Surg. 2008 85: 693-694. [Extract] [Full Text] [PDF]